背景:截至2019年,低收入和中等收入国家的高避孕需求未得到满足导致近一半的意外怀孕。其他男性避孕选择可能会有所帮助,但是在评估对它们的需求方面仍然存在差距。随着新型男性避孕药的发展,解决这些差距将有助于为政策和科学方向提供信息。
目的:测量消费者对新型男性避孕药的需求,并确定与男性偏好相关的产品属性。
方法:横截面,以概率为基础的抽样调查是对12,435人性活跃,肥沃的顺式性别,18-60岁的异性恋男性,和他们在孟加拉国的9122名女性伴侣,越南,肯尼亚,尼日利亚,刚果民主共和国,科特迪瓦从2021年5月到2022年10月。该调查还于2022年4月在美国对3,243名男性进行了调查。2023年5月,对3,070名男性进行了随访,评估了最高法院的Dobbs诉Jackson妇女卫生组织的裁决后需求的潜在变化。调查评估了避孕药具的使用,感知,和社会人口特征,离散选择实验评估了11种潜在产品属性的偏好。来自六个低收入国家的女性伴侣的数据表明了她们对男性伴侣使用避孕药具的兴趣和信任。
结果:平均而言,61%的男性在获得新的男性避孕药的第一年表现出了尝试的兴趣,从美国的39%和49%(多布斯之前和之后)到尼日利亚和孟加拉国的76%。管理形式和使用时间推动了男性的产品偏好。女性伴侣对男性避孕药具使用的兴趣和信任在不同地区都很高。
结论:这项研究揭示了对新型男性避孕药的强烈潜在需求,强调新型男性方法满足未满足需求的潜力,和女性伴侣信任男人使用它们。
结论:男性及其伴侣对新型男性避孕药的需求很高,支持投资发展。
BACKGROUND: As of 2019, high unmet contraceptive needs in low- and middle-income countries result in nearly half of all pregnancies being unintended. Additional male contraceptive options could help, but gaps remain in assessing demand for them. As the development of novel male contraceptives progresses, addressing these gaps would help inform policy and scientific direction.
OBJECTIVE: Measure consumer demand for novel male contraceptives and identify product attributes associated with men\'s preferences.
METHODS: A cross-sectional, probability-based-sample survey was conducted with 12,435 sexually active, fertile cisgender, heterosexual men aged 18-60 years, and 9,122 of their female partners in Bangladesh, Vietnam, Kenya, Nigeria, DR Congo, and Côte d\'Ivoire from May 2021 to October 2022. The survey was also conducted in the United States among 3,243 of these men in April 2022. A follow-up with 3,070 men in May 2023 assessed potential changes in demand after the Supreme Court\'s Dobbs v. Jackson Women\'s Health Organization decision. The surveys assessed contraceptive use, perceptions, and sociodemographic characteristics, and a discrete choice experiment evaluated preferences for 11 potential product attributes. Data from female partners in the six LMICs indicated their interest and trust in male partners\' contraceptive use.
RESULTS: On average, 61% of men showed interest in trying novel male contraceptives in their first year of availability, ranging from 39% and 49% (pre- and post-Dobbs) in the United States to 76% in Nigeria and Bangladesh. Form of administration and time of use drove men\'s product preferences. Female partners\' interest and trust in male contraceptive use were high across geographies.
CONCLUSIONS: This study reveals strong latent demand for novel male contraceptives, highlighting the potential for novel male methods to meet unmet needs, and female partners\' trust in men to use them.
CONCLUSIONS: High demand for novel male contraceptives among men and their partners exists, supporting investment in their development.